(Other OTC:RDGL),(OTC US:RDGL), Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) The IsoPet division reported an 800% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, the Company has seen a sharp rise in inbound inquiries from both veterinarians and pet owners seeking […]

(NASDAQ:VIVK), Dallas, TX, Dec. 22, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation service, announced today that it has signed a non-binding letter of intent to acquire Coyote Oilfield Services, LLC (“Coyote”), through its affiliate Vivakor Midstream, LLC. The proposed acquisition

(NASDAQ:DBGI), Austin, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (NASDAQ:DBGI) (the “Company,” “Digital Brands Group” or “DBG”) today announces continued progress in its strategy to build a comprehensive suite of technology-driven tools designed to protect, support, and grow modern consumer brands operating in global eCommerce markets. Brand misuse and counterfeiting have

(Other OTC:NGTF),(OTC US:NGTF), Los Angeles, CA, Dec. 22, 2025 (GLOBE NEWSWIRE) — via IBN — Nightfood Holdings, Inc. dba TechForce Robotics (OTCQB: NGTF) (“TechForce” or the “Company”), an AI-driven service-robotics platform focused on hospitality, foodservice, and commercial automation, today announces the development and pending launch of a new proprietary beverage dispensing robotic system. The new

(NASDAQ:LRHC), Celebration, FL, Dec. 22, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced a 31% annualized rate reduction in select technology operating costs to date, decreasing from approximately $0.52 million in 2022 to $0.17 million in 2025 resulting in a

(NasdaqGM:CRSP), -Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy data suggest significant clinical improvement in patients dosed at the 100 million cell dose, with the first systemic lupus erythematosus (SLE) patient achieving Definitions of Remission in SLE (DORIS) remission through Month 6- -An additional Phase

(NYSE MKT:KULR), HOUSTON , Dec. 22, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery systems for space and defense programs, hyperscale AI data centers, and telecom infrastructure OEMs, today announced that it has elected

(Other OTC:EDGM),(OTC US:EDGM), FORT LAUDERDALE, Fla., Dec. 22, 2025 (GLOBE NEWSWIRE) — EdgeMode (OTC: EDGM), a global Energy and AI data center infrastructure company, in a joint venture with Blackberry Alternative Investment Fund (BAIF), has announced a major operational milestone in the development of their large-scale AI data center platform in Spain: the necessary power

(NASDAQ:FMST),(CNSX:FAT.CN),(NASDAQ:FMSTW),(Frankfurt:F0R),(Frankfurt:F0R.F), VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce its plans for a $9 million exploration program in 2026 (the “2026 Exploration Program“), primarily focused on advancing its Athabasca Basin uranium projects. The Company maintains a portfolio of

BOSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced the successful dosing of the first patient in the United States in the TENACITY-01 clinical trial (NCT07070219). The TENACITY-01 trial is evaluating CTD402, Imviva's investigational allogeneic anti-CD7 CAR-T cell therapy, for the treatment of